(Q27077906)
Statements
543.191581±0 dalton
1 reference
929095-18-1 (English)
3 October 2016
C₂₇H₂₈F₃N₅O₂S
1 reference
929095-18-1 (English)
19 November 2016
CC(C1=CC=CC=C1C(F)(F)F)OC2=C(SC(=C2)N3C=NC4=C3C=C(C=C4)CN5CCN(CC5)C)C(=O)N
1 reference
929095-18-1 (English)
19 November 2016
C[C@H](C1=CC=CC=C1C(F)(F)F)OC2=C(SC(=C2)N3C=NC4=C3C=C(C=C4)CN5CCN(CC5)C)C(=O)N
1 reference
929095-18-1 (English)
19 November 2016
Identifiers
1 reference
929095-18-1 (English)
19 November 2016
2 references
929095-18-1 (English)
19 November 2016
2 references
gsk-461364 (English)
19 November 2016
1 reference
5-{6-[(4-Methyl-1-piperazinyl)methyl]-1H-benzimidazol-1-yl}-3-{(1R)-1-[2-(trifluoromethyl)phenyl]ethoxy}-2-thiophenecarboxamide (English)
19 November 2016
1 reference
929095-18-1 (English)
19 November 2016
1 reference
GSK-461364 (English)
19 November 2016
1 reference
GSK-461364A (English)
19 November 2016
1 reference
gsk-461364 (English)
19 November 2016